ANI Pharmaceuticals (ANIP)
(Delayed Data from NSDQ)
$67.25 USD
+0.14 (0.21%)
Updated May 3, 2024 04:00 PM ET
After-Market: $67.21 -0.04 (-0.06%) 7:58 PM ET
2-Buy of 5 2
B Value A Growth B Momentum A VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO5/10/24 |
---|---|
Current Quarter | 0.98 |
EPS Last Quarter | 1.00 |
Last EPS Surprise | 25.00% |
ABR | 1.20 |
Earnings ESP
|
9.74% |
---|---|
Current Year | 4.44 |
Next Year | 5.04 |
EPS (TTM) | 4.72 |
P/E (F1) | 15.16 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 125.01M | 130.37M | 533.69M | 576.24M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 128.03M | 131.97M | 537.57M | 585.00M |
Low Estimate | 122.10M | 128.00M | 529.60M | 563.66M |
Year ago Sales | 106.79M | 116.55M | 486.82M | 533.69M |
Year over Year Growth Est. | 17.06% | 11.85% | 9.63% | 7.97% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.98 | 1.06 | 4.44 | 5.04 |
# of Estimates | 4 | 4 | 4 | 4 |
Most Recent Consensus | 1.01 | 1.09 | 4.52 | 5.11 |
High Estimate | 1.07 | 1.09 | 4.54 | 5.39 |
Low Estimate | 0.88 | 1.01 | 4.31 | 4.54 |
Year ago EPS | 1.17 | 1.28 | 4.71 | 4.44 |
Year over Year Growth Est. | -16.24% | -17.19% | -5.73% | 13.63% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 0 | 1 | 1 |
Up Last 30 Days | 1 | 0 | 1 | 1 |
Up Last 60 Days | 1 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.98 | 1.06 | 4.44 | 5.04 |
7 Days Ago | 0.97 | 1.06 | 4.43 | 5.04 |
30 Days Ago | 0.97 | 1.06 | 4.43 | 5.04 |
60 Days Ago | 0.95 | 1.05 | 4.40 | 5.01 |
90 Days Ago | 0.83 | 0.99 | 4.06 | 4.80 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 1.07 | 1.06 | 4.31 | 4.54 |
Zacks Consensus Estimate | 0.98 | 1.06 | 4.44 | 5.04 |
Earnings ESP | 9.74% | 0.00% | -2.82% | -9.92% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 1.00 | 1.27 | 1.28 | 1.17 | NA |
Estimate | 0.80 | 0.76 | 0.64 | 0.34 | NA |
Difference | 0.20 | 0.51 | 0.64 | 0.83 | 0.55 |
Surprise | 25.00% | 67.11% | 100.00% | 244.12% | 109.06% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more